Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025

動物用ワクチンの世界市場予測:疾患別(豚肺炎、鳥インフルエンザ、狂犬病、コクシジウム症、ブルセラ症、犬ジステンパー)、種類別(家禽、家畜、水産養殖、豚、犬)、技術別(不活化、トキソイド、組換え)

◆タイトル:Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2025
◆商品コード:PH 3475
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:181
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は動物用ワクチンの世界市場が2020年80億ドルから2025年113億ドルまで、年平均7.2%成長すると予測しています。本調査レポートでは、動物用ワクチンの世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(ブタワクチン、家禽ワクチン、生菌ワクチン、コンパニオンアニマルワクチン、養殖ワクチン、その他動物用ワクチン)、病気別(豚病気、家禽病気、ライブストック病、コンパニオンアニマル疾患、養殖病)、技術別(ライブ弱毒化ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・動物用ワクチンの世界市場:種類別(ブタワクチン、家禽ワクチン、生菌ワクチン、コンパニオンアニマルワクチン、養殖ワクチン、その他動物用ワクチン)
・動物用ワクチンの世界市場:病気別(豚病気、家禽病気、ライブストック病、コンパニオンアニマル疾患、養殖病)
・動物用ワクチンの世界市場:技術別(ライブ弱毒化ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他)
・動物用ワクチンの世界市場:地域別
・競争状況
・企業概要

“The veterinary vaccines market is projected to grow at a CAGR of 7.2% during the forecast period (2020–2025).”
The global veterinary vaccines market size is projected to reach USD 11.3 billion by 2025 from USD 8.0 billion in 2020, at a CAGR of 7.2%. The growth of this market is driven majorly by factors such as the initiatives by various government agencies and animal associations to maintain animal health, rising incidence of zoonotic diseases, growth in the companion animal population, and the rising demand for animal-derived food products are driving the growth of this market. On the other hand, the high storage cost of vaccines is restraining market growth.

“By technology, the recombinant vaccines segment is expected to grow at the highest CAGR during the forecast period.”
Based on technology, the veterinary vaccines market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines. The recombinant vaccine segment is expected to register the highest growth during the forecast period. This growth in this segment is driven advantages offered by recombinant vaccines such as the lack of need for adjuvants, free from pathogen contamination, exhibit no post-vaccination reactions, and provide higher safety.

“By type, the porcine vaccines segment dominated the veterinary vaccines market in 2019.”
Based on type, the veterinary vaccines market is segmented porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and other animal vaccines. Porcine vaccines accounted for the largest share of the veterinary vaccines market in 2019, primarily due to the increasing porcine population, growing awareness about animal vaccination, and an outbreak of porcine diseases such as PRRS, swine influenza, and Aujeszky’s Disease.

“Asia Pacific veterinary vaccines market is expected to witness the highest growth during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–36%, Tier 2–45%, and Tier 3–19%
• By Designation: C-level–33%, Director-level–40%, and Others–27%
• By Region: North America–36%, Europe–28%, Asia Pacific–19%, RoW-17%

The prominent players operating in the global veterinary vaccines market include Zoetis (US), Boehringer Ingelheim (Germany), Merck (US), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France).
Research Coverage:
The report analyzes the veterinary vaccines market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a more significant share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the veterinary vaccines market
• Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the veterinary vaccines market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global veterinary vaccines market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the veterinary vaccines market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 30)

4 PREMIUM INSIGHTS (Page No. – 33)
4.1 VETERINARY VACCINES MARKET OVERVIEW
4.2 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY (2019)
4.3 SHARES OF MAJOR REGIONAL SEGMENTS IN THE VETERINARY VACCINES MARKET

5 MARKET OVERVIEW (Page No. – 36)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the companion animal population
5.2.1.2 Rising incidence of zoonotic diseases
5.2.1.3 Initiatives by various government agencies and animal associations
5.2.1.4 Rising demand for animal-derived food products
5.2.2 RESTRAINTS
5.2.2.1 High storage cost of vaccines
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Inadequate surveillance and reporting systems

6 VETERINARY VACCINES MARKET, BY TYPE (Page No. – 41)
6.1 INTRODUCTION
6.2 PORCINE VACCINES
6.2.1 PORCINE VACCINES SEGMENT DOMINATED THE MARKET IN 2019
6.3 POULTRY VACCINES
6.3.1 INCREASED PRODUCTION AND REARING OF POULTRY TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.4 LIVESTOCK VACCINES
6.4.1 BOVINE VACCINES
6.4.1.1 Bovine vaccines segment dominated the livestock vaccines market in 2019
6.4.2 SMALL RUMINANT VACCINES
6.4.2.1 Clostridial diseases and scabby mouth infection are some of the major diseases affecting small ruminants
6.5 COMPANION ANIMAL VACCINES
6.5.1 CANINE VACCINES
6.5.1.1 Canine vaccines segment dominated the companion animal vaccines market in 2019
6.5.2 FELINE VACCINES
6.5.2.1 Rising prevalence of zoonotic diseases to drive the demand for feline vaccines
6.6 AQUACULTURE VACCINES
6.6.1 VACCINATION PLAYS A CRUCIAL ROLE IN COMMERCIAL FISH FARMING
6.7 OTHER ANIMAL VACCINES

7 VETERINARY VACCINES MARKET, BY DISEASE (Page No. – 58)
7.1 INTRODUCTION
7.2 PORCINE DISEASES
7.3 POULTRY DISEASES
7.4 LIVESTOCK DISEASES
7.4.1 BOVINE DISEASES
7.4.2 SMALL RUMINANT DISEASES
7.5 COMPANION ANIMAL DISEASES
7.5.1 CANINE DISEASES
7.5.2 FELINE DISEASES
7.6 AQUACULTURE DISEASES

8 VETERINARY VACCINES MARKET, BY TECHNOLOGY (Page No. – 76)
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.2.1 LIVE ATTENUATED VACCINES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
8.3 INACTIVATED VACCINES
8.3.1 RISING NEED TO DEVELOP ARTIFICIAL IMMUNITY AGAINST DISEASES FROM NON-LIVING PATHOGENS IS A KEY FACTOR DRIVING THE GROWTH OF THE INACTIVATED VACCINES MARKET
8.4 TOXOID VACCINES
8.4.1 TOXOID VACCINES ARE USED WHEN A BACTERIAL TOXIN CAUSES AN ILLNESS
8.5 RECOMBINANT VACCINES
8.5.1 ADVANTAGES ASSOCIATED WITH RECOMBINANT VACCINES DRIVING THEIR DEMAND
8.6 OTHER VACCINES

9 VETERINARY VACCINES MARKET, BY REGION (Page No. – 86)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US is the largest market for veterinary vaccines in North America
9.2.2 CANADA
9.2.2.1 Rising pet and livestock populations in Canada to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Germany dominated the European veterinary vaccines market in 2019
9.3.2 UK
9.3.2.1 Growing pet adoption is increasing the demand for veterinary vaccines in the UK
9.3.3 FRANCE
9.3.3.1 Rising pet ownership to support market growth in France
9.3.4 ITALY
9.3.4.1 Increasing outbreaks of diseases to support market growth in Italy
9.3.5 SPAIN
9.3.5.1 Increase in the number of veterinary practices and the willingness to spend on animal healthcare to drive market growth in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 Outbreak of COVID-19 to affect the overall companion animal market in China
9.4.2 JAPAN
9.4.2.1 Increasing expenditure on pet healthcare to drive market growth in Japan
9.4.3 INDIA
9.4.3.1 Dearth of veterinarians to restrain market growth in India
9.4.4 THAILAND
9.4.4.1 Thailand is a major market for porcine vaccines in the Asia Pacific
9.4.5 REST OF APAC
9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE (Page No. – 134)
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS
10.3 COMPETITIVE SCENARIO
10.4 COMPETITIVE LEADERSHIP MAPPING, 2019
10.4.1 VISIONARY LEADERS
10.4.2 INNOVATORS
10.4.3 DYNAMIC DIFFERENTIATORS
10.4.4 EMERGING COMPANIES

11 COMPANY PROFILES (Page No. – 141)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis)*
11.1 ZOETIS
11.2 MERCK ANIMAL HEALTH
11.3 BOEHRINGER INGELHEIM
11.4 ELANCO
11.5 CEVA
11.6 VIRBAC
11.7 VETOQUINOL
11.8 PHIBRO ANIMAL HEALTH
11.9 HESTER BIOSCIENCES
11.10 HIPRA
11.11 BIOGENESIS BAGO
11.12 TIANJIN RINGPU
11.13 CHINA ANIMAL HUSBANDRY
11.14 JINYU BIO-TECHNOLOGY
11.15 OTHER COMPANIES
11.15.1 ENDOVAC ANIMAL HEALTH
11.15.2 BRILLIANT BIO PHARMA PRIVATE LIMITED
11.15.3 APTIMMUNE BIOLOGICS
11.15.4 INDIAN IMMUNOLOGICALS LTD.
11.15.5 TORIGEN
11.15.6 VEROVACCINES
* Business Overview, Products Offered, Recent Developments, Competitive Analysis might not be captured in case of unlisted companies.



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[動物用ワクチンの世界市場予測:疾患別(豚肺炎、鳥インフルエンザ、狂犬病、コクシジウム症、ブルセラ症、犬ジステンパー)、種類別(家禽、家畜、水産養殖、豚、犬)、技術別(不活化、トキソイド、組換え)]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆